A to D Program: From Academic Bench to Diagnostic Assay
Exosome Diagnostics is proud to offer a new program to partner with academic and clinical researchers, the “Academic Bench to Diagnostic Assay (A to D) Program”. This program is designed to utilize Exosome Dx’s developmental and regulatory expertise to bring your assays from the academic bench to the clinical diagnostics laboratory. Exosome Diagnostics' A to D program will help provide the expertise needed to address the challenges of advancing tests into the clinic:
- Navigation of the regulatory approval process
- Assistance with reimbursement
- Implementing a commercialization plan
- Leverages ExoDx’s patented exoRNeasy research kits (marketed by QIAGEN) with the benefit of working with Exosome Dx for the addition of cell free DNA for increased sensitivity of rare mutations when necessary.
Please note: Biomarkers developed using ExoRNEasy will be given priority in the collaboration pipeline.